ESC Congress Paris 2019
- Eamon Mulvaney
- Aug 26, 2019
- 1 min read
ATXA Therapeutics and PAH-Hope team members, Prof. Therese Kinsella & Dr. Helen Reid are looking forward to the ESC Congress 2019 next week. They will be onsite presenting preclinical findings of NTP42 for the treatment of PAH (Pulmonary Arterial Hytertension).
ESC Congress 2019 together with World Congress of Cardiology
Saturday 31 August - Wednesday 4 September 2019 Paris - France
Comments